SCHEMBL23535836

SCHEMBL23535836

C=C(c1ccc(Br)cc1)c1ccccn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 2/20 0.57
▸ L3MBTL1 Q9Y468 3/20 0.51
▸ GAA P10253 1/20 0.51
▸ KMT2A Q03164 4/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ MAPT P10636 4/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ CASP3 P42574 1/20 0.49
▸ SENP8 Q96LD8 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49
▸ SENP6 Q9GZR1 1/20 0.49
▸ PTGS2 P35354 1/20 0.45
▸ CES2 O00748 1/20 0.44
▸ CES1 P23141 1/20 0.44
▸ NPC1 O15118 4/20 0.43
▸ LMNA P02545 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ NAPRT Q6XQN6 1/20 0.42
▸ P4HTM Q9NXG6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30041522 1.00 TLR7 (0.57) TLR7L3MBTL1GAAKMT2AMEN1
SCHEMBL10824241 0.84 KMT2A (0.59) L3MBTL1GAAKMT2AMEN1MAPT
SCHEMBL29289285 0.81 TLR7 (0.58) TLR7L3MBTL1GAAKMT2AMEN1
SCHEMBL28576081 0.81 KMT2A (0.50) L3MBTL1KMT2AMEN1MAPTKDM4E
SCHEMBL1408599 0.80 CES2 (0.58) L3MBTL1GAAKMT2AMAPTKDM4E
SCHEMBL2956362 0.79 CES2 (0.41) TLR7L3MBTL1GAAKMT2AMEN1
SCHEMBL1156133 0.78 KMT2A (0.72) TLR7L3MBTL1GAAKMT2AMEN1
Methyl Alcohol SCHEMBL28478481 0.78 ALDH1A1 (0.58) L3MBTL1GAAKMT2AMAPTKDM4E
SCHEMBL17814199 0.77 TLR7 (0.61) TLR7L3MBTL1KMT2AMEN1MAPT
SCHEMBL29289270 0.77 RAB9A (0.60) L3MBTL1KMT2AMEN1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 — — US disclosed
CN-115427035-A ENL/AF9YEATS inhibitors 洛克菲勒大学 2022-12-02 — — CN disclosed
EP-4076440-A1 INHIBITORS OF ENL/AF9 YEATS The Rockefeller University (US) 2022-10-26 — — EP disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 — — WO disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS MLLT3, YEATS2, MLLT1 TLR7 3479/4885L3MBTL1 410/4885GAA 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback